6 Results for "

SOR

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "SOR" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P1651
CAS No.: 1187852-48-7
Target:  

TRP Channel

Research Areas:  

Cancer

SOR-C13, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel that is associated with malignancy and poor prognosis in breast cancer. SOR-C13 has anticancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1651A
Target:  

TRP Channel

Research Areas:  

Cancer

SOR-C13 TFA, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel that is associated with malignancy and poor prognosis in breast cancer. SOR-C13 TFA has anticancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1651B
Target:  

TRP Channel

Research Areas:  

Cancer

SOR-C13 acetate is the acetate salt form of SOR-C13 (HY-P1651). SOR-C13 acetate is an antagonist for transient receptor potential vanilloid 6 (TRPV 6), with an IC50 of 14 nM. SOR-C13 acetate inhibits tumor growth in SKOV-3 xenograft mouse model .
loading...
    loading...
Cat. No.: HY-RS17159
Research Areas:  

Others

Sri Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sri gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-151156
CAS No.: 2820126-50-7
Target:  

EGFR Apoptosis

Research Areas:  

Cancer

EGFR/HER2-IN-6 (compound 43) is an EGFR/HER2 and DHFR inhibitor. EGFR/HER2-IN-6 inhibits EGFR kinase, HER2 kinase and DHFR with IC50s of 0.122, 0.078 and 0.585 μM, respectively. EGFR/HER2-IN-6 shows anticancer activity against several cancer cell lines with high safety profile and selectivity indices. EGFR/HER2-IN-8 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-151161
CAS No.: 2820126-32-5
Target:  

EGFR

Research Areas:  

Cancer

EGFR/HER2-IN-8 (compound 34) is a EGFR/HER2 and DHFR inhibitor. EGFR/HER2-IN-8 inhibits EGFR kinase, HER2 kinase and DHFR with IC50s of 0.45, 0.244 and 5.669 μM, respectively. EGFR/HER2-IN-8 shows anticancer activity against several cancer cell lines with high safety profile and selectivity indices. EGFR/HER2-IN-8 can be used for the research of cancer .
loading...
    loading...